整理 | GLP1减重宝典内容团队 ▍ 颜如晶半年瘦身55斤 去年12月2日， 《奇葩说》辩手颜如晶因成功减重55斤 ，身穿红色长裙展现甜美公主风，迅速登上热搜，成为热议焦点。 最近明星、名人、企业家瘦身的消息特别多，以前却没有发生这种情况。减肥药的出现，确实会加速瘦身成功，而社交媒体的曝光会引 来更大的关注。 ▍"还是胖点好看！" 近日，话题 #张百乔瘦了60斤 #登上微博热搜 ，引发轰动。 8月26日，拥有两千万粉丝的网红兼演员张百乔在社交平台宣布已成功减重60斤，体重从228斤降至168斤，引起广泛关注。视频中，他 面部线条更加清晰，整体状态健康，还笑着问道："怎么样？"妻子小雪则打趣回应："还是胖点可爱，胖回去吧！" 次日，张百乔再次更新动态，晒出多张照片，包括训练场景及体重变化的记录。他写道："瘦六十斤留念，继续加油。"表达了继续保持 和锻炼的决心。 张百乔1996年9月21日出生于辽宁沈阳，毕业于河北传媒学院，是一名影视及小品演员。他曾参演过《"大"人物》《百万火急》《东北 喜事之山炮扶上墙》《这有浴池，欢迎光临》《金猪玉叶》《唐朝诡事录之西行》《窗前明月，咣！》《独一无二》《十二封信》《大 哥大 ...

Core Viewpoint - The article discusses the rising trend of weight loss among celebrities and entrepreneurs, highlighting the effectiveness of GLP-1 medications like Semaglutide and Tirzepatide in achieving significant weight loss results [2][15][31]. Group 1: Celebrity Weight Loss Stories - Yan Rujing lost 55 pounds (approximately 24.9 kg) over six months, starting from a weight of 196 pounds (approximately 89 kg) with a body fat percentage of 48.6% and a BMI of 40.27, indicating severe obesity [4][6]. - Lamei Yang achieved a weight loss of 20 pounds (approximately 9.1 kg) in just one month during the filming of "Sisters Who Make Waves," through an intense training regimen of 8 hours daily [7][11]. - Ma Weiwei lost 20 pounds (approximately 9.1 kg) in 45 days, adopting a low-carb diet and rigorous exercise, while also managing her mental health challenges related to depression [12][14]. Group 2: GLP-1 Medications Effectiveness - Semaglutide has shown an average weight loss of 15% in obese patients, significantly outperforming previous weight loss medications that typically resulted in a 5%-10% reduction [26][30]. - In clinical trials, Semaglutide demonstrated that over one-third of participants lost more than 20% of their body weight, while the placebo group only lost 2.4% [28]. - Tirzepatide has also proven effective, with studies showing an average weight loss of 15.4% to 22.9% in patients, significantly reducing the risk of diabetes progression [31][34].

Core Viewpoint - The article discusses the weight loss journey of Yang Tianzhen, highlighting her recent physical transformation and the methods she employed, including exercise and dietary changes, while clarifying that her weight loss is not solely due to traditional dieting methods [4][8]. Group 1: Yang Tianzhen's Weight Loss Journey - Yang Tianzhen has recently shared her weight loss progress, showcasing her commitment to exercise, particularly badminton, which has resulted in visible muscle definition [2][7]. - Despite public admiration for her efforts, there are mixed reactions, with some questioning the authenticity of her weight loss and others noting her previous statements against dieting [4]. - Yang underwent gastric surgery five years ago to manage diabetes, emphasizing that her primary motivation for the surgery was health-related rather than weight loss [4][5]. Group 2: Celebrity Weight Loss Trends - The article notes a surge in weight loss stories among celebrities, with many utilizing medications like Semaglutide and Tirzepatide for weight management [9]. - Elon Musk reported a weight loss of 30 pounds (approximately 27.2 kg) using Semaglutide [9]. - Other celebrities, including Whoopi Goldberg and Kelly Clarkson, have also shared their experiences with weight loss medications, highlighting significant weight reductions [11][13]. Group 3: Efficacy of Semaglutide - Clinical trials (STEP series) indicate that Semaglutide can lead to an average weight loss of 15% to 18% in obese patients, significantly outperforming placebo groups [21][26]. - In the STEP 1 trial, participants lost an average of 14.9% of their body weight, with over one-third losing more than 20% [23]. - The FDA approved Semaglutide for long-term weight management in adults with obesity or overweight conditions in June 2021, marking it as a significant advancement in obesity treatment [26]. Group 4: Efficacy of Tirzepatide - The SURMOUNT studies demonstrate that Tirzepatide can achieve substantial weight loss, with participants losing up to 26.6% of their body weight over 72 weeks [31]. - In the SURMOUNT-2 trial, patients with type 2 diabetes lost an average of 15.7% of their body weight, showcasing the drug's effectiveness [29]. - The FDA approved Tirzepatide for obesity treatment based on its promising results in clinical trials [30].